A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

NCT02467387 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Ischemic Heart Failure

Interventions

DRUG: Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)
DRUG: Lactated Ringer's Solution

Sponsor

CardioCell LLC

Collaborators

[object Object]